Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2017, Article ID 8245879, 9 pages
https://doi.org/10.1155/2017/8245879
Research Article

Maternal and Perinatal Outcome in Women with Systemic Lupus Erythematosus: A Retrospective Bicenter Cohort Study

1Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, P.O. Box 85500, 3508 GA Utrecht, Netherlands
2Department of Obstetrics and Gynecology, VU University Medical Center, P.O. Box 7057, 1007 MB Amsterdam, Netherlands
3Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, VU University Medical Center, P.O. Box 7057, 1007 MB Amsterdam, Netherlands
4Department of Obstetrics and Gynecology, University Medical Center Utrecht, P.O. Box 85500, 3508 GA Utrecht, Netherlands
51st Medical Department and Ludwig Boltzmann Institute of Osteology at the Hanusch Hospital of WGKK, Vienna, Austria
6AUVA Trauma Centre Meidling, Hanusch Hospital, Vienna, Austria
7Sigmund Freud University, Vienna, Austria

Correspondence should be addressed to Sylvia J. Kroese; ln.thcertucmu@2-eseork.j.s

Received 26 May 2017; Revised 28 July 2017; Accepted 8 August 2017; Published 28 September 2017

Academic Editor: Jacek Tabarkiewicz

Copyright © 2017 Sylvia J. Kroese et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Al-Maini, T. Jeyalingam, P. Brown et al., “A hot spot for systemic lupus erythematosus, but not for psoriatic arthritis, identified by spatial analysis suggests an interaction between ethnicity and place of residence,” Arthritis and Rheumatism, vol. 65, no. 6, pp. 1579–1585, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. M. E. Clowse, “Lupus activity in pregnancy,” Rheumatic Diseases Clinics of North America, vol. 33, no. 2, pp. 237–52, v, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Petri, D. Howard, and J. Repke, “Frequency of lupus flare in pregnancy. The Hopkins lupus pregnancy center experience,” Arthritis and Rheumatism, vol. 34, no. 12, pp. 1538–1545, 1991. View at Google Scholar
  4. M. B. Urowitz, D. D. Gladman, V. T. Farewell, J. Stewart, and J. McDonald, “Lupus and pregnancy studies,” Arthritis and Rheumatism, vol. 36, no. 10, pp. 1392–1397, 1993. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Ostensen and M. Clowse, “Pathogenesis of pregnancy complications in systemic lupus erythematosus,” Current Opinion in Rheumatology, vol. 25, no. 5, pp. 591–596, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. M. E. Clowse, M. Jamison, E. Myers, and A. H. James, “A national study of the complications of lupus in pregnancy,” American Journal of Obstetrics and Gynecology, vol. 199, no. 2, pp. 127–126, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. S. Yan, A. Krizova, J. M. Ouimet, and J. E. Pope, “Pregnancy outcome in systemic lupus erythematosus (SLE) is improving: results from a case control study and literature review,” The Open Rheumatology Journal, vol. 2, pp. 89–98, 2008. View at Publisher · View at Google Scholar
  8. H. S. Ko, H. Y. Ahn, D. G. Jang et al., “Pregnancy outcomes and appropriate timing of pregnancy in 183 pregnancies in Korean patients with SLE,” International Journal of Medical Sciences, vol. 8, no. 7, pp. 577–583, 2011. View at Publisher · View at Google Scholar
  9. K. Bramham, B. J. Hunt, S. Bewley et al., “Pregnancy outcomes in systemic lupus erythematosus with and without previous nephritis,” The Journal of Rheumatology, vol. 38, no. 9, pp. 1906–1913, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. O. Ateka-Barrutia and M. Khamashta, “The challenge of pregnancy for patients with SLE,” Lupus, vol. 22, no. 12, pp. 1295–1308, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Moroni, A. Doria, E. Giglio et al., “Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study,” Journal of Autoimmunity, vol. 74, pp. 194–200, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Moroni, A. Doria, E. Giglio et al., “Fetal outcome and recommendations of pregnancies in lupus nephritis in the 21st century. A prospective multicenter study,” Journal of Autoimmunity, vol. 74, pp. 6–12, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Lateef and M. Petri, “Managing lupus patients during pregnancy,” Best Practice & Research. Clinical Rheumatology, vol. 27, no. 3, pp. 435–447, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. T. J. Stanhope, W. M. White, K. G. Moder, A. Smyth, and V. D. Garovic, “Obstetric nephrology: lupus and lupus nephritis in pregnancy,” Clinical Journal of the American Society of Nephrology, vol. 7, no. 12, pp. 2089–2099, 2012. View at Publisher · View at Google Scholar
  15. G. Burkett, “Lupus nephropathy and pregnancy,” Clinical Obstetrics and Gynecology, vol. 28, no. 2, pp. 310–323, 1985. View at Publisher · View at Google Scholar
  16. G. Ruiz-Irastorza and M. A. Khamashta, “Lupus and pregnancy: integrating clues from the bench and bedside,” European Journal of Clinical Investigation, vol. 41, no. 6, pp. 672–678, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Barbhaiya and B. L. Bermas, “Evaluation and management of systemic lupus erythematosus and rheumatoid arthritis during pregnancy,” Clinical Immunology, vol. 149, no. 2, pp. 225–235, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. M. E. Clowse, L. Magder, F. Witter, and M. Petri, “Hydroxychloroquine in lupus pregnancy,” Arthritis and Rheumatism, vol. 54, no. 11, pp. 3640–3647, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. C. A. Clark, K. A. Spitzer, and C. A. Laskin, “Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period,” The Journal of Rheumatology, vol. 32, no. 9, pp. 1709–1712, 2005. View at Google Scholar
  20. J. P. Buyon, M. Y. Kim, M. M. Guerra et al., “Predictors of pregnancy outcomes in patients with lupus: a cohort study,” Annals of Internal Medicine, vol. 163, no. 3, pp. 153–163, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. M. F. van Oostwaard, J. Langenveld, E. Schuit et al., “Recurrence of hypertensive disorders of pregnancy: an individual patient data metaanalysis,” American Journal of Obstetrics and Gynecology, vol. 212, no. 5, pp. 624–617, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. M. C. Hochberg, “Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 40, no. 9, p. 1725, 1997. View at Google Scholar
  23. M. Petri, A. M. Orbai, G. S. Alarcón et al., “Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 64, no. 8, pp. 2677–2686, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. W. A. Wilson, A. E. Gharavi, T. Koike et al., “International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop,” Arthritis and Rheumatism, vol. 42, no. 7, pp. 1309–1311, 1999. View at Publisher · View at Google Scholar
  25. S. Miyakis, M. D. Lockshin, T. Atsumi et al., “International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS),” Journal of Thrombosis and Haemostasis, vol. 4, no. 2, pp. 295–306, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Bombardier, D. D. Gladman, M. B. Urowitz, D. Caron, and C. H. Chang, “Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE,” Arthritis and Rheumatism, vol. 35, no. 6, 1992. View at Google Scholar
  27. J. P. Buyon, K. C. Kalunian, R. Ramsey-Goldman et al., “Assessing disease activity in SLE patients during pregnancy,” Lupus, vol. 8, no. 8, pp. 677–684, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. J. P. Buyon, M. A. Petri, M. Y. Kim et al., “The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial,” Annals of Internal Medicine, vol. 142, 12, Part 1, pp. 953–962, 2005. View at Publisher · View at Google Scholar
  29. C. N. Abheiden, B. S. Blomjous, S. J. Kroese et al., “Low-molecular-weight heparin and aspirin use in relation to pregnancy outcome in women with systemic lupus erythematosus and antiphospholipid syndrome: a cohort study,” Hypertension in Pregnancy, vol. 36, pp. 8–15, 2017. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Blencowe, S. Cousens, M. Z. Oestergaard et al., “National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications,” Lancet, vol. 379, no. 9832, pp. 2162–2172, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. J. A. Hutcheon, S. Lisonkova, and K. S. Joseph, “Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy,” Best Practice & Research. Clinical Obstetrics & Gynaecology, vol. 25, no. 4, pp. 391–403, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. H. D. Le, B. Wechsler, D. Vauthier-Brouzes et al., “Outcome of planned pregnancies in systemic lupus erythematosus: a prospective study on 62 pregnancies,” British Journal of Rheumatology, vol. 36, no. 7, pp. 772–777, 1997. View at Publisher · View at Google Scholar
  33. J. Cortes-Hernandez, J. Ordi-Ros, F. Paredes, M. Casellas, F. Castillo, and M. Vilardell-Tarres, “Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies,” Rheumatology (Oxford, England), vol. 41, no. 6, pp. 643–650, 2002. View at Google Scholar
  34. M. Leroux, C. Desveaux, M. Parcevaux et al., “Impact of hydroxychloroquine on preterm delivery and intrauterine growth restriction in pregnant women with systemic lupus erythematosus: a descriptive cohort study,” Lupus, vol. 24, no. 13, pp. 1384–1391, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. R. A. Levy, V. S. Vilela, M. J. Cataldo et al., “Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study,” Lupus, vol. 10, no. 6, pp. 401–404, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. E. F. Chakravarty, I. Colon, E. S. Langen et al., “Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus,” American Journal of Obstetrics and Gynecology, vol. 192, no. 6, pp. 1897–1904, 2005. View at Google Scholar
  37. S. Appenzeller, F. H. Souza, S. A. Wagner Silva de, Y. Shoenfeld, and J. F. de Carvalho, “HELLP syndrome and its relationship with antiphospholipid syndrome and antiphospholipid antibodies,” Seminars in Arthritis and Rheumatism, vol. 41, no. 3, pp. 517–523, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. T. D. Le Thi, N. Tieulie, N. Costedoat et al., “The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women,” Annals of the Rheumatic Diseases, vol. 64, no. 2, pp. 273–278, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Ambrosio, R. Lermann, A. Cordeiro, A. Borges, I. Nogueira, and F. Serrano, “Lupus and pregnancy—15 years of experience in a tertiary center,” Clinical Reviews in Allergy & Immunology, vol. 38, no. 2-3, pp. 77–81, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. C. A. Clark, K. A. Spitzer, J. N. Nadler, and C. A. Laskin, “Preterm deliveries in women with systemic lupus erythematosus,” The Journal of Rheumatology, vol. 30, no. 10, pp. 2127–2132, 2003. View at Google Scholar
  41. J. Francois, “Congenital glaucoma and its inheritance,” Ophthalmologica, vol. 181, pp. 61–73, 1972. View at Publisher · View at Google Scholar
  42. A. Gencik, A. Gencikova, and V. Ferák, “Population genetical aspects of primary congenital glaucoma. I. Incidence, prevalence, gene frequency, and age of onset,” Human Genetics, vol. 61, no. 3, pp. 193–197, 1982. View at Publisher · View at Google Scholar · View at Scopus
  43. A. W. Shand, C. S. Algert, L. March, and C. L. Roberts, “Second pregnancy outcomes for women with systemic lupus erythematosus,” Annals of the Rheumatic Diseases, vol. 72, no. 4, pp. 547–551, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. D. Cudihy and R. V. Lee, “The pathophysiology of pre-eclampsia: current clinical concepts,” Journal of Obstetrics and Gynaecology, vol. 29, no. 7, pp. 576–582, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. C. J. Hardy, B. P. Palmer, S. J. Morton, K. R. Muir, and R. J. Powell, “Pregnancy outcome and family size in systemic lupus erythematosus: a case-control study,” Rheumatology (Oxford, England), vol. 38, no. 6, pp. 559–563, 1999. View at Publisher · View at Google Scholar · View at Scopus